|
- 2019
Optimal Duration for Clopidogrel Suspension Prior to Coronary Artery Bypass GraftingDOI: 10.14740/cr842 Keywords: Clopidogrel, CABG, Bleeding risk Abstract: American College of Cardiology (ACC) guidelines suggest clopidogrel (Plavix) suspension for 5 days before non-emergent cardiac surgery (class IIa, level B). It puts the patients with recent angioplasty and ongoing ischemia at a higher risk of stent thrombosis. We sought to determine the bleeding risk in patients who stopped clopidogrel at 3 and less than 3 days before coronary artery bypass grafting (CABG) as compared to the usual 5 days prior to CABG
|